TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)
$18.26 0.15 (0.8283%)
Analysed TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) News Sources
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera
28-08-2026
yahoo.com
FDA OKs Takeda, Protagonist drug for rare blood cancer
31-08-2026
biopharmadive.com
Sector Update: Healthcare Stocks Decline Late Afternoon
31-08-2026
yahoo.com
The Bull Case For Protagonist Therapeutics (PTGX) Could Change Following FDA Approval Of MIMRYLO And Takeda Milestones
01-09-2026
yahoo.com
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
01-09-2026
yahoo.com
Takeda and Weave Bio collaborate on AI-driven automation in drug development
02-09-2026
pharmaceutical-technology.com
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB
02-09-2026
yahoo.com
Protagonist Therapeutics Announces $300 Million Share Repurchase Program
08-09-2026
yahoo.com
Trialbee to Present with Takeda, Showcase AI for Clinical Sites, and Unveil AI-Powered Patient Screening at DPHARM 2026
09-09-2026
yahoo.com
Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
10-09-2026
biopharmadive.com
What is the current price of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)?
The current price of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) is $18.26.
TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) absolute price change since previous trading day?
The absolute price change of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) since the previous trading day is $0.15.
TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) percentage price change since previous trading day?
The percentage price change of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) since the previous trading day is 0.8283%.
What is the most recent average sentiment score for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)?
The most recent average sentiment score for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) is 68 out of 100.
What is the most recent average sentiment for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)?
The most recent sentiment for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) is .
SEC-8K** Filing Available For TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.